Nutra Pharma Corp. (OTCMKTS:NPHC) is a development-stage pharmaceutical and nutraceutical company focused on the licensing, development and commercialization of proprietary therapies and wellness products. The company’s pharmaceutical pipeline centers on non-opioid analgesics, antimicrobial peptides and biologics aimed at addressing pain management, chronic wound care and infectious diseases. In its nutraceutical division, Nutra Pharma markets proprietary dietary supplements formulated to support joint health, immune function and general wellbeing.
Headquartered in Las Vegas, Nevada, Nutra Pharma maintains research and development facilities in North America as well as a European affiliate dedicated to clinical trial support and regulatory affairs. The company collaborates with contract research organizations and academic institutions to advance preclinical studies and Phase I/II trials. Nutra Pharma distributes its nutraceutical line through e-commerce channels and a network of specialty retailers across the United States, Canada and select European markets.
Since its incorporation in the early 2000s, Nutra Pharma has evolved through strategic acquisitions and internal restructuring to sharpen its focus on high-growth therapeutic areas. Under the stewardship of CEO David R. Turner, the company has streamlined operations to prioritize late-stage development of its lead candidate, NPL200, designed for chronic neuropathic pain. A seasoned management team oversees manufacturing, supply chain logistics and regulatory strategy to advance product candidates toward commercialization.
Looking ahead, Nutra Pharma aims to complete pivotal clinical trials and pursue regulatory approvals in key jurisdictions. The company continues to explore strategic partnerships and licensing agreements to expand its pharmaceutical pipeline while broadening its nutraceutical portfolio. These efforts are intended to strengthen its position in the non-opioid pain management sector and deliver innovative health solutions to global markets.
AI Generated. May Contain Errors.
Free NPHC Stock Alerts